APA

Ciccolini J., Evrard A., M'Batchi L., Pourroy B., Mercier C., Iliadis A., Lacarelle B., Verschuur A., Ouafik L. & André N. (20120801). CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations. : Pharmacogenomics.

Chicago

Ciccolini Joseph, Evrard Alexandre, M'Batchi Lithaty, Pourroy Bertrand, Mercier Cédric, Iliadis Athanassios, Lacarelle Bruno, Verschuur Arnaud, Ouafik L'Houcine and André Nicolas. 20120801. CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations. : Pharmacogenomics.

Harvard

Ciccolini J., Evrard A., M'Batchi L., Pourroy B., Mercier C., Iliadis A., Lacarelle B., Verschuur A., Ouafik L. and André N. (20120801). CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations. : Pharmacogenomics.

MLA

Ciccolini Joseph, Evrard Alexandre, M'Batchi Lithaty, Pourroy Bertrand, Mercier Cédric, Iliadis Athanassios, Lacarelle Bruno, Verschuur Arnaud, Ouafik L'Houcine and André Nicolas. CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations. : Pharmacogenomics. 20120801.